Published: Aug-2022|  Format: PDF | QY Research |  Number of pages: 108 | Code: MBI-917136

Atypical Antipsychotic Drugs Market by Products (Risperidone, Olanzapine, Quetiapine, Ziprasidone), by Applications (Bipolar I Disorder, Schizophrenia, Schizoaffective Disorder, Major Depressive Disorder (MDD)) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 - 2028

Select a Format




 Buy Now

The Global Atypical Antipsychotic Drugs Market was valued at USD XXX in 2022 and it is projected to surpass around USD XX by 2030 with a registered CAGR of xxx during the forecast period 2022 to 2030.

Growth factor

Our new latest report titled, global Atypical Antipsychotic Drugs market comes up with comprehensive analysis of the industry including emerging trends and current development of the market. The report offers comprehensive insights of the industry with details of market share, size, revenue, growth opportunities, regional insights and major companies. The report provides all necessary and vital information related to the global market to help the buyer, the readers, investors get a complete understanding of the market and invest accordingly to the upcoming challenges and opportunities.

List of Key Players Operating in the Market:

The report provides in-depth research about each player operating in the global Atypical Antipsychotic Drugs market along with its worldwide financial position, previous and upcoming business expansion plans, new product launches. The upcoming activities of the key players related to various strategies such as acquisitions, partnerships, mergers and, joint ventures, research and development investments.

  • Novartis AG
  • Cardinal Health
  • Johnson and Johnson
  • Allergan
  • Sanis Health
  • Pfizer
  • GlaxoSmithKline
  • Bristol-Myers Squibb Company
  • Sun Pharmaceutical Industries
  • Eil Lilly and Company
  • AstraZeneca
  • Sumitomo Dainippon Pharma
  • Qilu Pharmaceutical

Market research report presents an analysis of all the data collected through primary and secondary resources. Our well experienced team of analyst collects all the information from several leading entities press release, government publication sources such as gold standard, silver standard, white papers, articles and websites, corporate filings including financial statements, annual reports, investor presentations, etc.

Our Report offers detailed insights market valuation, volume, share, outlook, production capacity and price analysis for the forecast period 2022-2030. Furthermore, the study also includes market segmentation on the basis of product, application, end-users, supply chain, distribution channel and other segment. Additionally, the study also includes market segmentation based on upstream downstream demand analysis, feedstock, and consumption rate and market share. It employs both primary and secondary methods of data collection to obtain relevant and sustainable information of the market.

This exclusive report includes detailed information about the market related activities such as Partnerships, stake holder position, Sole Traders, which create, develop, and conduct activities for the study and analysis of markets as per the customization and specifications of the client.

Segment Analysis of the Market:

The objective of the report mainly provides an essential overview of the Atypical Antipsychotic Drugs market with detailed market segmentation by product, end-users, distribution channel, technology, content, type, application and region. The global market is expected to witness rapid growth during the forecast period. The report provides growth drivers, challenges, restraints of the region. It also offers the fastest growing segment with future scope, advancement emerging trends. The study examines the global scenario of the market by conducting an economy-wide assessment along with a comprehensive study involving product costs, drivers and restrictions, demands, profit analysis, production, distribution, and year-on-year growth rates.

By Type

  • Risperidone
  • Olanzapine
  • Quetiapine
  • Ziprasidone
  • Others

By Application

  • Bipolar I Disorder
  • Schizophrenia
  • Schizoaffective Disorder
  • Major Depressive Disorder (MDD)

Key Question Answered in this In-depth Market Report 2022-2028:

  • What was the market valued in the past year?
  • What will be the projected size, share and CAGR of the market?
  • What was the market status across the globe?
  • What are the profit margins in global Atypical Antipsychotic Drugs market?
  • What are the growth factors boosts the market for the forecast period?
  • Which segment is going to boom in the near future?
  • What are the upcoming trends of the market?
  • Who are the key companies or players of the market?
  • Which is the fastest growing region of the global Atypical Antipsychotic Drugs market?

Regional Insights:

The government initiative increasing the development activities of the Atypical Antipsychotic Drugs market. On the other hand the major reason behind the growth is the market key players are expanding their operation in this region.

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Exclusive Report Offers:

  1. To study and analyze the global Atypical Antipsychotic Drugs market consumption rate by key regions, type and application, historical data from past five years, and for upcoming years.
  2. The global research study look at the market to identify key influencing factors and entry barriers.
  3. To understand the structure of market by identifying and studying its various segments.
  4. To analyze with respect to individual prospects, growth factors, emerging trends, and their contribution to the whole market.
  5. Study focuses on the analysis of key players, to describe and analyze the sales volume, company size, share, value, market competition landscape, SWOT analysis and development plans in the near future.
1 Study Coverage
    1.1 Atypical Antipsychotic Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Atypical Antipsychotic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Risperidone
        1.2.3 Olanzapine
        1.2.4 Quetiapine
        1.2.5 Ziprasidone
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Atypical Antipsychotic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Bipolar I Disorder
        1.3.3 Schizophrenia
        1.3.4 Schizoaffective Disorder
        1.3.5 Major Depressive Disorder (MDD)
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Atypical Antipsychotic Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Atypical Antipsychotic Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Atypical Antipsychotic Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Atypical Antipsychotic Drugs Sales by Region
        2.4.1 Global Atypical Antipsychotic Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Atypical Antipsychotic Drugs by Region (2023-2028)
    2.5 Global Atypical Antipsychotic Drugs Revenue by Region
        2.5.1 Global Atypical Antipsychotic Drugs Revenue by Region (2017-2022)
        2.5.2 Global Atypical Antipsychotic Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Atypical Antipsychotic Drugs Sales by Manufacturers
        3.1.1 Global Top Atypical Antipsychotic Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Atypical Antipsychotic Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Atypical Antipsychotic Drugs in 2021
    3.2 Global Atypical Antipsychotic Drugs Revenue by Manufacturers
        3.2.1 Global Atypical Antipsychotic Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Atypical Antipsychotic Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Atypical Antipsychotic Drugs Revenue in 2021
    3.3 Global Atypical Antipsychotic Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Atypical Antipsychotic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Atypical Antipsychotic Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Atypical Antipsychotic Drugs Sales by Type
        4.1.1 Global Atypical Antipsychotic Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Atypical Antipsychotic Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Atypical Antipsychotic Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Atypical Antipsychotic Drugs Revenue by Type
        4.2.1 Global Atypical Antipsychotic Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Atypical Antipsychotic Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Atypical Antipsychotic Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Atypical Antipsychotic Drugs Price by Type
        4.3.1 Global Atypical Antipsychotic Drugs Price by Type (2017-2022)
        4.3.2 Global Atypical Antipsychotic Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Atypical Antipsychotic Drugs Sales by Application
        5.1.1 Global Atypical Antipsychotic Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Atypical Antipsychotic Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Atypical Antipsychotic Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Atypical Antipsychotic Drugs Revenue by Application
        5.2.1 Global Atypical Antipsychotic Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Atypical Antipsychotic Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Atypical Antipsychotic Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Atypical Antipsychotic Drugs Price by Application
        5.3.1 Global Atypical Antipsychotic Drugs Price by Application (2017-2022)
        5.3.2 Global Atypical Antipsychotic Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Atypical Antipsychotic Drugs Market Size by Type
        6.1.1 North America Atypical Antipsychotic Drugs Sales by Type (2017-2028)
        6.1.2 North America Atypical Antipsychotic Drugs Revenue by Type (2017-2028)
    6.2 North America Atypical Antipsychotic Drugs Market Size by Application
        6.2.1 North America Atypical Antipsychotic Drugs Sales by Application (2017-2028)
        6.2.2 North America Atypical Antipsychotic Drugs Revenue by Application (2017-2028)
    6.3 North America Atypical Antipsychotic Drugs Market Size by Country
        6.3.1 North America Atypical Antipsychotic Drugs Sales by Country (2017-2028)
        6.3.2 North America Atypical Antipsychotic Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Atypical Antipsychotic Drugs Market Size by Type
        7.1.1 Europe Atypical Antipsychotic Drugs Sales by Type (2017-2028)
        7.1.2 Europe Atypical Antipsychotic Drugs Revenue by Type (2017-2028)
    7.2 Europe Atypical Antipsychotic Drugs Market Size by Application
        7.2.1 Europe Atypical Antipsychotic Drugs Sales by Application (2017-2028)
        7.2.2 Europe Atypical Antipsychotic Drugs Revenue by Application (2017-2028)
    7.3 Europe Atypical Antipsychotic Drugs Market Size by Country
        7.3.1 Europe Atypical Antipsychotic Drugs Sales by Country (2017-2028)
        7.3.2 Europe Atypical Antipsychotic Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Atypical Antipsychotic Drugs Market Size by Type
        8.1.1 Asia Pacific Atypical Antipsychotic Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Atypical Antipsychotic Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Atypical Antipsychotic Drugs Market Size by Application
        8.2.1 Asia Pacific Atypical Antipsychotic Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Atypical Antipsychotic Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Atypical Antipsychotic Drugs Market Size by Region
        8.3.1 Asia Pacific Atypical Antipsychotic Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Atypical Antipsychotic Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Atypical Antipsychotic Drugs Market Size by Type
        9.1.1 Latin America Atypical Antipsychotic Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Atypical Antipsychotic Drugs Revenue by Type (2017-2028)
    9.2 Latin America Atypical Antipsychotic Drugs Market Size by Application
        9.2.1 Latin America Atypical Antipsychotic Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Atypical Antipsychotic Drugs Revenue by Application (2017-2028)
    9.3 Latin America Atypical Antipsychotic Drugs Market Size by Country
        9.3.1 Latin America Atypical Antipsychotic Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Atypical Antipsychotic Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Atypical Antipsychotic Drugs Market Size by Type
        10.1.1 Middle East and Africa Atypical Antipsychotic Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Atypical Antipsychotic Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Atypical Antipsychotic Drugs Market Size by Application
        10.2.1 Middle East and Africa Atypical Antipsychotic Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Atypical Antipsychotic Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Atypical Antipsychotic Drugs Market Size by Country
        10.3.1 Middle East and Africa Atypical Antipsychotic Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Atypical Antipsychotic Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Novartis AG
        11.1.1 Novartis AG Corporation Information
        11.1.2 Novartis AG Overview
        11.1.3 Novartis AG Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Novartis AG Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Novartis AG Recent Developments
    11.2 Cardinal Health
        11.2.1 Cardinal Health Corporation Information
        11.2.2 Cardinal Health Overview
        11.2.3 Cardinal Health Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Cardinal Health Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Cardinal Health Recent Developments
    11.3 Johnson and Johnson
        11.3.1 Johnson and Johnson Corporation Information
        11.3.2 Johnson and Johnson Overview
        11.3.3 Johnson and Johnson Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Johnson and Johnson Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Johnson and Johnson Recent Developments
    11.4 Allergan
        11.4.1 Allergan Corporation Information
        11.4.2 Allergan Overview
        11.4.3 Allergan Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Allergan Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Allergan Recent Developments
    11.5 Sanis Health
        11.5.1 Sanis Health Corporation Information
        11.5.2 Sanis Health Overview
        11.5.3 Sanis Health Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Sanis Health Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Sanis Health Recent Developments
    11.6 Pfizer
        11.6.1 Pfizer Corporation Information
        11.6.2 Pfizer Overview
        11.6.3 Pfizer Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Pfizer Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Pfizer Recent Developments
    11.7 GlaxoSmithKline
        11.7.1 GlaxoSmithKline Corporation Information
        11.7.2 GlaxoSmithKline Overview
        11.7.3 GlaxoSmithKline Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 GlaxoSmithKline Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 GlaxoSmithKline Recent Developments
    11.8 Bristol-Myers Squibb Company
        11.8.1 Bristol-Myers Squibb Company Corporation Information
        11.8.2 Bristol-Myers Squibb Company Overview
        11.8.3 Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Bristol-Myers Squibb Company Recent Developments
    11.9 Sun Pharmaceutical Industries
        11.9.1 Sun Pharmaceutical Industries Corporation Information
        11.9.2 Sun Pharmaceutical Industries Overview
        11.9.3 Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Sun Pharmaceutical Industries Recent Developments
    11.10 Eil Lilly and Company
        11.10.1 Eil Lilly and Company Corporation Information
        11.10.2 Eil Lilly and Company Overview
        11.10.3 Eil Lilly and Company Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Eil Lilly and Company Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Eil Lilly and Company Recent Developments
    11.11 AstraZeneca
        11.11.1 AstraZeneca Corporation Information
        11.11.2 AstraZeneca Overview
        11.11.3 AstraZeneca Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 AstraZeneca Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 AstraZeneca Recent Developments
    11.12 Sumitomo Dainippon Pharma
        11.12.1 Sumitomo Dainippon Pharma Corporation Information
        11.12.2 Sumitomo Dainippon Pharma Overview
        11.12.3 Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Sumitomo Dainippon Pharma Recent Developments
    11.13 Qilu Pharmaceutical
        11.13.1 Qilu Pharmaceutical Corporation Information
        11.13.2 Qilu Pharmaceutical Overview
        11.13.3 Qilu Pharmaceutical Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Qilu Pharmaceutical Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Qilu Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Atypical Antipsychotic Drugs Industry Chain Analysis
    12.2 Atypical Antipsychotic Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Atypical Antipsychotic Drugs Production Mode & Process
    12.4 Atypical Antipsychotic Drugs Sales and Marketing
        12.4.1 Atypical Antipsychotic Drugs Sales Channels
        12.4.2 Atypical Antipsychotic Drugs Distributors
    12.5 Atypical Antipsychotic Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Atypical Antipsychotic Drugs Industry Trends
    13.2 Atypical Antipsychotic Drugs Market Drivers
    13.3 Atypical Antipsychotic Drugs Market Challenges
    13.4 Atypical Antipsychotic Drugs Market Restraints
14 Key Findings in The Global Atypical Antipsychotic Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables Table 1. Global Atypical Antipsychotic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Risperidone Table 3. Major Manufacturers of Olanzapine Table 4. Major Manufacturers of Quetiapine Table 5. Major Manufacturers of Ziprasidone Table 6. Major Manufacturers of Others Table 7. Global Atypical Antipsychotic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 8. Global Atypical Antipsychotic Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 9. Global Atypical Antipsychotic Drugs Sales by Region (2017-2022) & (K Units) Table 10. Global Atypical Antipsychotic Drugs Sales Market Share by Region (2017-2022) Table 11. Global Atypical Antipsychotic Drugs Sales by Region (2023-2028) & (K Units) Table 12. Global Atypical Antipsychotic Drugs Sales Market Share by Region (2023-2028) Table 13. Global Atypical Antipsychotic Drugs Revenue by Region (2017-2022) & (US$ Million) Table 14. Global Atypical Antipsychotic Drugs Revenue Market Share by Region (2017-2022) Table 15. Global Atypical Antipsychotic Drugs Revenue by Region (2023-2028) & (US$ Million) Table 16. Global Atypical Antipsychotic Drugs Revenue Market Share by Region (2023-2028) Table 17. Global Atypical Antipsychotic Drugs Sales by Manufacturers (2017-2022) & (K Units) Table 18. Global Atypical Antipsychotic Drugs Sales Share by Manufacturers (2017-2022) Table 19. Global Atypical Antipsychotic Drugs Revenue by Manufacturers (2017-2022) & (US$ Million) Table 20. Global Atypical Antipsychotic Drugs Revenue Share by Manufacturers (2017-2022) Table 21. Atypical Antipsychotic Drugs Price by Manufacturers (2017-2022) &(USD/Unit) Table 22. Global Atypical Antipsychotic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Global Atypical Antipsychotic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atypical Antipsychotic Drugs as of 2021) Table 24. Atypical Antipsychotic Drugs Manufacturing Base Distribution and Headquarters Table 25. Manufacturers Atypical Antipsychotic Drugs Product Offered Table 26. Date of Manufacturers Enter into Atypical Antipsychotic Drugs Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Atypical Antipsychotic Drugs Sales by Type (2017-2022) & (K Units) Table 29. Global Atypical Antipsychotic Drugs Sales by Type (2023-2028) & (K Units) Table 30. Global Atypical Antipsychotic Drugs Sales Share by Type (2017-2022) Table 31. Global Atypical Antipsychotic Drugs Sales Share by Type (2023-2028) Table 32. Global Atypical Antipsychotic Drugs Revenue by Type (2017-2022) & (US$ Million) Table 33. Global Atypical Antipsychotic Drugs Revenue by Type (2023-2028) & (US$ Million) Table 34. Global Atypical Antipsychotic Drugs Revenue Share by Type (2017-2022) Table 35. Global Atypical Antipsychotic Drugs Revenue Share by Type (2023-2028) Table 36. Atypical Antipsychotic Drugs Price by Type (2017-2022) & (USD/Unit) Table 37. Global Atypical Antipsychotic Drugs Price Forecast by Type (2023-2028) & (USD/Unit) Table 38. Global Atypical Antipsychotic Drugs Sales by Application (2017-2022) & (K Units) Table 39. Global Atypical Antipsychotic Drugs Sales by Application (2023-2028) & (K Units) Table 40. Global Atypical Antipsychotic Drugs Sales Share by Application (2017-2022) Table 41. Global Atypical Antipsychotic Drugs Sales Share by Application (2023-2028) Table 42. Global Atypical Antipsychotic Drugs Revenue by Application (2017-2022) & (US$ Million) Table 43. Global Atypical Antipsychotic Drugs Revenue by Application (2023-2028) & (US$ Million) Table 44. Global Atypical Antipsychotic Drugs Revenue Share by Application (2017-2022) Table 45. Global Atypical Antipsychotic Drugs Revenue Share by Application (2023-2028) Table 46. Atypical Antipsychotic Drugs Price by Application (2017-2022) & (USD/Unit) Table 47. Global Atypical Antipsychotic Drugs Price Forecast by Application (2023-2028) & (USD/Unit) Table 48. North America Atypical Antipsychotic Drugs Sales by Type (2017-2022) & (K Units) Table 49. North America Atypical Antipsychotic Drugs Sales by Type (2023-2028) & (K Units) Table 50. North America Atypical Antipsychotic Drugs Revenue by Type (2017-2022) & (US$ Million) Table 51. North America Atypical Antipsychotic Drugs Revenue by Type (2023-2028) & (US$ Million) Table 52. North America Atypical Antipsychotic Drugs Sales by Application (2017-2022) & (K Units) Table 53. North America Atypical Antipsychotic Drugs Sales by Application (2023-2028) & (K Units) Table 54. North America Atypical Antipsychotic Drugs Revenue by Application (2017-2022) & (US$ Million) Table 55. North America Atypical Antipsychotic Drugs Revenue by Application (2023-2028) & (US$ Million) Table 56. North America Atypical Antipsychotic Drugs Sales by Country (2017-2022) & (K Units) Table 57. North America Atypical Antipsychotic Drugs Sales by Country (2023-2028) & (K Units) Table 58. North America Atypical Antipsychotic Drugs Revenue by Country (2017-2022) & (US$ Million) Table 59. North America Atypical Antipsychotic Drugs Revenue by Country (2023-2028) & (US$ Million) Table 60. Europe Atypical Antipsychotic Drugs Sales by Type (2017-2022) & (K Units) Table 61. Europe Atypical Antipsychotic Drugs Sales by Type (2023-2028) & (K Units) Table 62. Europe Atypical Antipsychotic Drugs Revenue by Type (2017-2022) & (US$ Million) Table 63. Europe Atypical Antipsychotic Drugs Revenue by Type (2023-2028) & (US$ Million) Table 64. Europe Atypical Antipsychotic Drugs Sales by Application (2017-2022) & (K Units) Table 65. Europe Atypical Antipsychotic Drugs Sales by Application (2023-2028) & (K Units) Table 66. Europe Atypical Antipsychotic Drugs Revenue by Application (2017-2022) & (US$ Million) Table 67. Europe Atypical Antipsychotic Drugs Revenue by Application (2023-2028) & (US$ Million) Table 68. Europe Atypical Antipsychotic Drugs Sales by Country (2017-2022) & (K Units) Table 69. Europe Atypical Antipsychotic Drugs Sales by Country (2023-2028) & (K Units) Table 70. Europe Atypical Antipsychotic Drugs Revenue by Country (2017-2022) & (US$ Million) Table 71. Europe Atypical Antipsychotic Drugs Revenue by Country (2023-2028) & (US$ Million) Table 72. Asia Pacific Atypical Antipsychotic Drugs Sales by Type (2017-2022) & (K Units) Table 73. Asia Pacific Atypical Antipsychotic Drugs Sales by Type (2023-2028) & (K Units) Table 74. Asia Pacific Atypical Antipsychotic Drugs Revenue by Type (2017-2022) & (US$ Million) Table 75. Asia Pacific Atypical Antipsychotic Drugs Revenue by Type (2023-2028) & (US$ Million) Table 76. Asia Pacific Atypical Antipsychotic Drugs Sales by Application (2017-2022) & (K Units) Table 77. Asia Pacific Atypical Antipsychotic Drugs Sales by Application (2023-2028) & (K Units) Table 78. Asia Pacific Atypical Antipsychotic Drugs Revenue by Application (2017-2022) & (US$ Million) Table 79. Asia Pacific Atypical Antipsychotic Drugs Revenue by Application (2023-2028) & (US$ Million) Table 80. Asia Pacific Atypical Antipsychotic Drugs Sales by Region (2017-2022) & (K Units) Table 81. Asia Pacific Atypical Antipsychotic Drugs Sales by Region (2023-2028) & (K Units) Table 82. Asia Pacific Atypical Antipsychotic Drugs Revenue by Region (2017-2022) & (US$ Million) Table 83. Asia Pacific Atypical Antipsychotic Drugs Revenue by Region (2023-2028) & (US$ Million) Table 84. Latin America Atypical Antipsychotic Drugs Sales by Type (2017-2022) & (K Units) Table 85. Latin America Atypical Antipsychotic Drugs Sales by Type (2023-2028) & (K Units) Table 86. Latin America Atypical Antipsychotic Drugs Revenue by Type (2017-2022) & (US$ Million) Table 87. Latin America Atypical Antipsychotic Drugs Revenue by Type (2023-2028) & (US$ Million) Table 88. Latin America Atypical Antipsychotic Drugs Sales by Application (2017-2022) & (K Units) Table 89. Latin America Atypical Antipsychotic Drugs Sales by Application (2023-2028) & (K Units) Table 90. Latin America Atypical Antipsychotic Drugs Revenue by Application (2017-2022) & (US$ Million) Table 91. Latin America Atypical Antipsychotic Drugs Revenue by Application (2023-2028) & (US$ Million) Table 92. Latin America Atypical Antipsychotic Drugs Sales by Country (2017-2022) & (K Units) Table 93. Latin America Atypical Antipsychotic Drugs Sales by Country (2023-2028) & (K Units) Table 94. Latin America Atypical Antipsychotic Drugs Revenue by Country (2017-2022) & (US$ Million) Table 95. Latin America Atypical Antipsychotic Drugs Revenue by Country (2023-2028) & (US$ Million) Table 96. Middle East and Africa Atypical Antipsychotic Drugs Sales by Type (2017-2022) & (K Units) Table 97. Middle East and Africa Atypical Antipsychotic Drugs Sales by Type (2023-2028) & (K Units) Table 98. Middle East and Africa Atypical Antipsychotic Drugs Revenue by Type (2017-2022) & (US$ Million) Table 99. Middle East and Africa Atypical Antipsychotic Drugs Revenue by Type (2023-2028) & (US$ Million) Table 100. Middle East and Africa Atypical Antipsychotic Drugs Sales by Application (2017-2022) & (K Units) Table 101. Middle East and Africa Atypical Antipsychotic Drugs Sales by Application (2023-2028) & (K Units) Table 102. Middle East and Africa Atypical Antipsychotic Drugs Revenue by Application (2017-2022) & (US$ Million) Table 103. Middle East and Africa Atypical Antipsychotic Drugs Revenue by Application (2023-2028) & (US$ Million) Table 104. Middle East and Africa Atypical Antipsychotic Drugs Sales by Country (2017-2022) & (K Units) Table 105. Middle East and Africa Atypical Antipsychotic Drugs Sales by Country (2023-2028) & (K Units) Table 106. Middle East and Africa Atypical Antipsychotic Drugs Revenue by Country (2017-2022) & (US$ Million) Table 107. Middle East and Africa Atypical Antipsychotic Drugs Revenue by Country (2023-2028) & (US$ Million) Table 108. Novartis AG Corporation Information Table 109. Novartis AG Description and Major Businesses Table 110. Novartis AG Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 111. Novartis AG Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 112. Novartis AG Recent Developments Table 113. Cardinal Health Corporation Information Table 114. Cardinal Health Description and Major Businesses Table 115. Cardinal Health Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 116. Cardinal Health Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 117. Cardinal Health Recent Developments Table 118. Johnson and Johnson Corporation Information Table 119. Johnson and Johnson Description and Major Businesses Table 120. Johnson and Johnson Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 121. Johnson and Johnson Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 122. Johnson and Johnson Recent Developments Table 123. Allergan Corporation Information Table 124. Allergan Description and Major Businesses Table 125. Allergan Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 126. Allergan Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 127. Allergan Recent Developments Table 128. Sanis Health Corporation Information Table 129. Sanis Health Description and Major Businesses Table 130. Sanis Health Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 131. Sanis Health Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 132. Sanis Health Recent Developments Table 133. Pfizer Corporation Information Table 134. Pfizer Description and Major Businesses Table 135. Pfizer Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 136. Pfizer Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 137. Pfizer Recent Developments Table 138. GlaxoSmithKline Corporation Information Table 139. GlaxoSmithKline Description and Major Businesses Table 140. GlaxoSmithKline Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 141. GlaxoSmithKline Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 142. GlaxoSmithKline Recent Developments Table 143. Bristol-Myers Squibb Company Corporation Information Table 144. Bristol-Myers Squibb Company Description and Major Businesses Table 145. Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 146. Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 147. Bristol-Myers Squibb Company Recent Developments Table 148. Sun Pharmaceutical Industries Corporation Information Table 149. Sun Pharmaceutical Industries Description and Major Businesses Table 150. Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 151. Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 152. Sun Pharmaceutical Industries Recent Developments Table 153. Eil Lilly and Company Corporation Information Table 154. Eil Lilly and Company Description and Major Businesses Table 155. Eil Lilly and Company Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 156. Eil Lilly and Company Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 157. Eil Lilly and Company Recent Developments Table 158. AstraZeneca Corporation Information Table 159. AstraZeneca Description and Major Businesses Table 160. AstraZeneca Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 161. AstraZeneca Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 162. AstraZeneca Recent Developments Table 163. Sumitomo Dainippon Pharma Corporation Information Table 164. Sumitomo Dainippon Pharma Description and Major Businesses Table 165. Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 166. Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 167. Sumitomo Dainippon Pharma Recent Developments Table 168. Qilu Pharmaceutical Corporation Information Table 169. Qilu Pharmaceutical Description and Major Businesses Table 170. Qilu Pharmaceutical Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 171. Qilu Pharmaceutical Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 172. Qilu Pharmaceutical Recent Developments Table 173. Key Raw Materials Lists Table 174. Raw Materials Key Suppliers Lists Table 175. Atypical Antipsychotic Drugs Distributors List Table 176. Atypical Antipsychotic Drugs Customers List Table 177. Atypical Antipsychotic Drugs Market Trends Table 178. Atypical Antipsychotic Drugs Market Drivers Table 179. Atypical Antipsychotic Drugs Market Challenges Table 180. Atypical Antipsychotic Drugs Market Restraints Table 181. Research Programs/Design for This Report Table 182. Key Data Information from Secondary Sources Table 183. Key Data Information from Primary Sources List of Figures Figure 1. Atypical Antipsychotic Drugs Product Picture Figure 3. Global Atypical Antipsychotic Drugs Market Share by Type in 2021 & 2028 Figure 3. Risperidone Product Picture Figure 4. Olanzapine Product Picture Figure 5. Quetiapine Product Picture Figure 6. Ziprasidone Product Picture Figure 7. Others Product Picture Figure 8. Global Atypical Antipsychotic Drugs Market Share by Application in 2021 & 2028 Figure 9. Bipolar I Disorder Figure 10. Schizophrenia Figure 11. Schizoaffective Disorder Figure 12. Major Depressive Disorder (MDD) Figure 13. Atypical Antipsychotic Drugs Report Years Considered Figure 14. Global Atypical Antipsychotic Drugs Sales 2017-2028 (K Units) Figure 15. Global Atypical Antipsychotic Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 16. Global Atypical Antipsychotic Drugs Revenue 2017-2028 (US$ Million) Figure 17. Global Atypical Antipsychotic Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 18. Global Atypical Antipsychotic Drugs Sales Market Share by Region (2017-2022) Figure 19. Global Atypical Antipsychotic Drugs Sales Market Share by Region (2023-2028) Figure 20. North America Atypical Antipsychotic Drugs Sales YoY (2017-2028) & (K Units) Figure 21. North America Atypical Antipsychotic Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 22. Europe Atypical Antipsychotic Drugs Sales YoY (2017-2028) & (K Units) Figure 23. Europe Atypical Antipsychotic Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 24. Asia-Pacific Atypical Antipsychotic Drugs Sales YoY (2017-2028) & (K Units) Figure 25. Asia-Pacific Atypical Antipsychotic Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 26. Latin America Atypical Antipsychotic Drugs Sales YoY (2017-2028) & (K Units) Figure 27. Latin America Atypical Antipsychotic Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 28. Middle East & Africa Atypical Antipsychotic Drugs Sales YoY (2017-2028) & (K Units) Figure 29. Middle East & Africa Atypical Antipsychotic Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 30. The Atypical Antipsychotic Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 31. The Top 5 and 10 Largest Manufacturers of Atypical Antipsychotic Drugs in the World: Market Share by Atypical Antipsychotic Drugs Revenue in 2021 Figure 32. Global Atypical Antipsychotic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 33. Global Atypical Antipsychotic Drugs Sales Market Share by Type (2017-2028) Figure 34. Global Atypical Antipsychotic Drugs Revenue Market Share by Type (2017-2028) Figure 35. Global Atypical Antipsychotic Drugs Sales Market Share by Application (2017-2028) Figure 36. Global Atypical Antipsychotic Drugs Revenue Market Share by Application (2017-2028) Figure 37. North America Atypical Antipsychotic Drugs Sales Market Share by Type (2017-2028) Figure 38. North America Atypical Antipsychotic Drugs Revenue Market Share by Type (2017-2028) Figure 39. North America Atypical Antipsychotic Drugs Sales Market Share by Application (2017-2028) Figure 40. North America Atypical Antipsychotic Drugs Revenue Market Share by Application (2017-2028) Figure 41. North America Atypical Antipsychotic Drugs Sales Share by Country (2017-2028) Figure 42. North America Atypical Antipsychotic Drugs Revenue Share by Country (2017-2028) Figure 43. U.S. Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 44. Canada Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 45. Europe Atypical Antipsychotic Drugs Sales Market Share by Type (2017-2028) Figure 46. Europe Atypical Antipsychotic Drugs Revenue Market Share by Type (2017-2028) Figure 47. Europe Atypical Antipsychotic Drugs Sales Market Share by Application (2017-2028) Figure 48. Europe Atypical Antipsychotic Drugs Revenue Market Share by Application (2017-2028) Figure 49. Europe Atypical Antipsychotic Drugs Sales Share by Country (2017-2028) Figure 50. Europe Atypical Antipsychotic Drugs Revenue Share by Country (2017-2028) Figure 51. Germany Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 52. France Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 53. U.K. Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 54. Italy Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 55. Russia Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 56. Asia Pacific Atypical Antipsychotic Drugs Sales Market Share by Type (2017-2028) Figure 57. Asia Pacific Atypical Antipsychotic Drugs Revenue Market Share by Type (2017-2028) Figure 58. Asia Pacific Atypical Antipsychotic Drugs Sales Market Share by Application (2017-2028) Figure 59. Asia Pacific Atypical Antipsychotic Drugs Revenue Market Share by Application (2017-2028) Figure 60. Asia Pacific Atypical Antipsychotic Drugs Sales Share by Region (2017-2028) Figure 61. Asia Pacific Atypical Antipsychotic Drugs Revenue Share by Region (2017-2028) Figure 62. China Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 63. Japan Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 64. South Korea Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 65. India Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 66. Australia Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 67. Taiwan Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 68. Indonesia Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 69. Thailand Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 70. Malaysia Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 71. Philippines Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 72. Latin America Atypical Antipsychotic Drugs Sales Market Share by Type (2017-2028) Figure 73. Latin America Atypical Antipsychotic Drugs Revenue Market Share by Type (2017-2028) Figure 74. Latin America Atypical Antipsychotic Drugs Sales Market Share by Application (2017-2028) Figure 75. Latin America Atypical Antipsychotic Drugs Revenue Market Share by Application (2017-2028) Figure 76. Latin America Atypical Antipsychotic Drugs Sales Share by Country (2017-2028) Figure 77. Latin America Atypical Antipsychotic Drugs Revenue Share by Country (2017-2028) Figure 78. Mexico Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 79. Brazil Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 80. Argentina Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 81. Middle East and Africa Atypical Antipsychotic Drugs Sales Market Share by Type (2017-2028) Figure 82. Middle East and Africa Atypical Antipsychotic Drugs Revenue Market Share by Type (2017-2028) Figure 83. Middle East and Africa Atypical Antipsychotic Drugs Sales Market Share by Application (2017-2028) Figure 84. Middle East and Africa Atypical Antipsychotic Drugs Revenue Market Share by Application (2017-2028) Figure 85. Middle East and Africa Atypical Antipsychotic Drugs Sales Share by Country (2017-2028) Figure 86. Middle East and Africa Atypical Antipsychotic Drugs Revenue Share by Country (2017-2028) Figure 87. Turkey Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 88. Saudi Arabia Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 89. U.A.E Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million) Figure 90. Atypical Antipsychotic Drugs Value Chain Figure 91. Atypical Antipsychotic Drugs Production Process Figure 92. Channels of Distribution Figure 93. Distributors Profiles Figure 94. Bottom-up and Top-down Approaches for This Report Figure 95. Data Triangulation Figure 96. Key Executives Interviewed



Inquiry before buying

Request Sample

Request for Discount

Latest News

Global Cancer Immunotherapy Market to Grow at a (CAGR) of 13.9% during the Forecast Period 2022-2030

18-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global  Cancer Immunotherapy Market is projected to reach USD 275.5 billion by 2030. Moreover, increasing day-by-day incidence of cancer, increasing awareness about early diagnosis, the effectiveness of thera ...

Global In-Vehicle Infotainment Market to Grow at a (CAGR) of 9.8% during the Forecast Period 2022-2030

17-Nov-2022 | Automobile

As specified in our exclusive report, the global  In-Vehicle Infotainment Market is projected to reach USD 42.25 billion by 2030. In-vehicle infotainment systems provide entertainment and information services to the driver and passengers throughou ...

Global Blockchain in Healthcare Market to Grow at a (CAGR) of 59% during the Forecast Period 2022-2030

16-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global Blockchain in Healthcare Market is projected to reach USD 119 billion by 2030. The growing need for curbing these issues along with the increasing incidence of information leaks and data breaches has be ...

Global In Vitro Fertilization Market to Grow at a (CAGR) of 5.7% during the Forecast Period 2022-2030

14-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the Global In-Vitro Fertilization Market is projected to reach USD 32 billion by 2030. In-vitro fertilization involves some risks such as genetic disease transfer during the pr ...

Global Microfluidics Market to Grow at a (CAGR) of 15.8% during the Forecast Period 2022-2030

11-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global  Microfluidics Market is projected to reach USD 61 billion by 2030. The growth in demand for point-of-care (POC) devices is expected to majorly drive the market size in the coming years. Simultaneously demand ...

More News...